Structural differences between the human and mouse 52-kD Ro autoantigens associated with poorly conserved autoantibody activity across species

被引:20
作者
Keech, CL [1 ]
Gordon, TP [1 ]
McCluskey, J [1 ]
机构
[1] FLINDERS UNIV S AUSTRALIA, MED CTR, CTR TRANSFUS MED & IMMUNOL, BEDFORD PK, SA 5042, AUSTRALIA
关键词
autoantigens; Ro/SS-A; 52-kDRo;
D O I
10.1046/j.1365-2249.1996.16726.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Anti-nuclear autoantibodies found in human autoimmune diseases frequently cross-react with homologous autoantigens in distant species, supporting the notion that autoantibodies target conserved functional domains. However, the 52-kD Ro(SS-A) protein is an exception, in that human autoantibodies are not known to recognize any equivalent antigen in the cells of rodents and other non-primate species. To understand this lack of cross-reactivity we have isolated cDNAs encoding the mouse 52-kD Ro molecule. The cDNA encoding mouse 52-kD Ro revealed an open reading frame of 470 amino acids, with 70% sequence identity to the human 52-kD Ro antigen. The putative leucine-zipper and zinc-finger motifs present in human Ro52 were conserved in the mouse protein. Recombinant mouse 52-kD Ro protein reacted with human autoantibodies by ELISA and immunoblot, but with approximately 10-fold lower reactivity than recombinant human 52-kD Ro protein under the same conditions. Detection of both human and mouse 52-kD Ro by immunoblot was dependent on antigen concentration which was limiting in the cell equivalents generally used in immunoblot assays. Differential chaotropic disruption of antibody binding suggested a lower avidity of human autoantibody binding to the mouse 52-kD Ro protein compared with the human antigen. Thus the poor reactivity of native mouse 52-kD Ro with human autoantibodies is associated with species divergence diffusely distributed throughout the primary structure of the 52-kD Ro molecule.
引用
收藏
页码:255 / 263
页数:9
相关论文
共 30 条
[1]   IDENTIFICATION OF ANTIGENIC REGIONS OF THE HUMAN 52KD RO/SS-A PROTEIN RECOGNIZED BY PATIENT SERA [J].
BLANGE, I ;
RINGERTZ, NR ;
PETTERSSON, I .
JOURNAL OF AUTOIMMUNITY, 1994, 7 (02) :263-274
[2]  
BOZIC B, 1993, CLIN EXP IMMUNOL, V94, P227
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   PREPARATION OF BACTERIOPHAGE-LAMBDA DNA USING THE TL-100 ULTRACENTRIFUGE [J].
BUCKLEY, MF ;
GODING, JW .
ANALYTICAL BIOCHEMISTRY, 1988, 175 (01) :281-283
[5]  
BUYON JP, 1994, J IMMUNOL, V152, P3675
[6]   MOLECULAR DEFINITION AND SEQUENCE MOTIFS OF THE 52-KD COMPONENT OF HUMAN SS-A/RO AUTOANTIGEN [J].
CHAN, EKL ;
HAMEL, JC ;
BUYON, JP ;
TAN, EM .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (01) :68-76
[7]  
FRANK MB, 1993, AM J HUM GENET, V52, P183
[8]  
FRANK MB, 1994, CLIN EXP IMMUNOL, V95, P390
[9]   RESTRICTED EPITOPE RECOGNITION BY PRECIPITIN-NEGATIVE ANTI-LA/SS-B-POSITIVE SERA [J].
GORDON, T ;
MAVRANGELOS, C ;
MCCLUSKEY, J .
ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :663-666
[10]   MOLECULAR-CLONING AND PRELIMINARY CHARACTERIZATION OF A NOVEL CYTOPLASMIC ANTIGEN RECOGNIZED BY MYASTHENIA-GRAVIS SERA [J].
GORDON, T ;
GROVE, B ;
LOFTUS, JC ;
OTOOLE, T ;
MCMILLAN, R ;
LINDSTROM, J ;
GINSBERG, MH .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) :992-999